自噬对三叉神经节神经元五羟色胺受体3的调节及其在三叉神经痛中的作用

基本信息
批准号:81300965
项目类别:青年科学基金项目
资助金额:23.00
负责人:王旭辉
学科分类:
依托单位:中国人民解放军第三军医大学
批准年份:2013
结题年份:2016
起止时间:2014-01-01 - 2016-12-31
项目状态: 已结题
项目参与者:邹咏文,陈莎,易良,贺绪智,梁鸿
关键词:
mTOR自噬五羟色胺五羟色胺受体3三叉神经痛
结项摘要

Trigeminal neuralgia is defined as sudden, severe, brief, stabbing recurrent episodes of pain within the distribution of one or more branches of the trigeminal nerve, which has a profound effect on quality of life. For the cause of Trigeminal neuralgia remains unclear, its treatment is still unsatisfactory. In previous research our group found that the level of 5-HT significant rised in the cerebrospinal fluid of the patients suffered by Trigeminal neuralgia, which demonstrated the improtant role of 5-HT in this disease. Further,based on the previous discovery that the serotonin receptor-3 is highly expressed in the peripheral parts of the trigeminal nerve by the introduction of serotonin, which increase the reaction to the mechanical stimulation, our further research found that serotonin may inhibit the autophagic degradation of 5-HTR3 through the PI3K/AKT/mTOR pathway which may be involved in the hyperalgesia of trigeminal nerve, but its mechanism is still unknown. This project intends to adopt the serial molecular biological techniques, such as laser scanning confocal microscope, transmission electron microscope, western blotting, immunofluorescence and animal behavior tests. By way of primary cultured trigeminal ganglion neurons and animal models we would clarify the relationship between 5-HT in inhibiting the autophagic degradation of 5-HTR3 that is invovled in hyperalgesia of trigeminal nerve, and then investigate the underlying mechanisms by which 5-HT regulates the autophagy. This project aims at improving the understanding of the etiology and attack mechanism, provide the new idea and therapeutic targets of the Trigeminal neuralgia.

三叉神经痛是面部三叉神经支配区域反复发作的剧烈疼痛,严重影响患者生活质量。由于其病因尚未完全阐明,治疗效果不甚理想。本课题组前期发现三叉神经痛患者脑脊液内5-HT水平升高,并据此在三叉神经痛动物模型中证明:在5-HT刺激下,三叉神经外周部分5-HTR3高表达,其明显增加疼痛反应,且此过程与自噬水平相关。进一步研究发现,5-HT可能通过PI3K/Akt/mTOR信号通路,抑制自噬,参与5-HTR3表达升高及疼痛反应,但其具体机制尚不清楚。本项目拟采用激光共聚焦、透射电镜、Western Blot、免疫荧光、动物行为学实验等方法,从三叉神经节原代神经元及三叉神经痛动物模型两个水平,明确5-HT对自噬的调节作用,及其与5-HTR3的表达量和三叉神经痛之间的关系。并探讨5-HT调节自噬及三叉神经痛的可能分子机制。将有助于完善对三叉神经痛发作机制的认识,为临床治疗三叉神经痛提供新的思路和靶点。

项目摘要

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

Protective effect of Schisandra chinensis lignans on hypoxia-induced PC12 cells and signal transduction

Protective effect of Schisandra chinensis lignans on hypoxia-induced PC12 cells and signal transduction

DOI:10.1080/15287394.2018.1502561
发表时间:2018
2

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

DOI:
发表时间:2016
3

基于 Kronecker 压缩感知的宽带 MIMO 雷达高分辨三维成像

基于 Kronecker 压缩感知的宽带 MIMO 雷达高分辨三维成像

DOI:10.11999/JEIT150995
发表时间:2016
4

Engineering Leaf-Like UiO-66-SO_3H Membranes for Selective Transport of Cations

Engineering Leaf-Like UiO-66-SO_3H Membranes for Selective Transport of Cations

DOI:10.1007/s40820-020-0386-6
发表时间:2020
5

The Role of Osteokines in Sarcopenia: Therapeutic Directions and Application Prospects

The Role of Osteokines in Sarcopenia: Therapeutic Directions and Application Prospects

DOI:10.3389/fcell.2021.735374
发表时间:2021

王旭辉的其他基金

批准号:61179066
批准年份:2011
资助金额:39.00
项目类别:联合基金项目
批准号:61772167
批准年份:2017
资助金额:63.00
项目类别:面上项目
批准号:11301131
批准年份:2013
资助金额:22.00
项目类别:青年科学基金项目
批准号:11126198
批准年份:2011
资助金额:3.00
项目类别:数学天元基金项目
批准号:71201086
批准年份:2012
资助金额:19.00
项目类别:青年科学基金项目

相似国自然基金

1

黄藤素对三叉神经节P2X7受体介导的三叉神经痛的作用研究

批准号:81860199
批准年份:2018
负责人:熊伟
学科分类:H1506
资助金额:35.00
项目类别:地区科学基金项目
2

长非编码RNAuc.48+在三叉神经痛中的作用研究

批准号:81460106
批准年份:2014
负责人:熊伟
学科分类:H1506
资助金额:47.00
项目类别:地区科学基金项目
3

同步化放电在三叉神经痛中的作用及其Cx43-EAATs的分子调控机制

批准号:81771101
批准年份:2017
负责人:黄东
学科分类:H1506
资助金额:56.00
项目类别:面上项目
4

酪胺受体TAAR1参与三叉神经痛及其机制研究

批准号:31800879
批准年份:2018
负责人:孙玉芳
学科分类:C0904
资助金额:26.00
项目类别:青年科学基金项目